The PERMET trial will determine whether metformin daily for six months improves six-minute walk performance in individuals with peripheral artery disease compared to placebo.
- Investigator
- Scott A Berceli
- Ages
- 18 Years - N/A
- Sexes
- All
Clinical trials
-
PERMET